RACHAEL HAMELINK: Open Payments
NPI 1841845658 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 17 payments from 10 companies in 2025. Trend: 2023 $124 · 2024 $0 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $82 |
| ABBVIE INC. | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $54 |
| QOL Medical, LLC | 2 | $54 |
| Biocon Biologics Inc | 1 | $39 |
| Ardelyx, Inc. | 1 | $30 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| VIVUS LLC | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: XELJANZ, ENTYVIO, TREMFYA, Sucraid, Yesintek, RINVOQ, IBSRELA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
